| 中文名称 | 1,7'-二甲基-2'-丙基-1H,1'H-2,5'-二苯并[d]咪唑 |
|---|---|
| 中文别名 | 2-正丙基-4-甲基-6-(1'-甲基苯并咪唑-2-基)苯并咪唑;双咪唑;2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑;双咪唑 [or 2-正丙基-4-甲基-6-(1´-甲基苯骈咪唑-2-基)苯并咪唑];2-正丙基-4-甲基-6-(1’-甲基苯并咪唑-2-基)苯并咪唑;2-正丙基-4-甲基-6-（1’-甲基苯并咪唑-2-基）苯并咪唑 (双咪唑);2-正丙基-4-甲基-6-(1''-甲基苯并咪唑-2-基)苯并咪唑;2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑(双咪唑);4'-溴甲基联苯-2-羧酸甲酯;沙坦类中间体;替米沙坦杂质A;替米沙坦杂质A(EP) 标准品;替米沙坦中间体;替米沙坦双咪唑;2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑 (简称:双咪唑);2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑,MPB;双咪唑 [or 2-正丙基-4-甲基-6-(1'-甲基苯骈咪唑-2-基)苯骈咪唑];替米沙坦中间体(双咪唑);替米沙坦相关物质A;替米沙坦EP杂质A;2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪 |
| 英文名称 | 1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazole |
| 英文别名 | 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole;2-n-Propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazole;Bis-Benzoimidazole 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) –benzimidazole;2-n-Propyl-4-Methyl-6-(1-Methyl Benzimidazole-2-yl)-Benzimidazole;2-n-Propyl-4-methyl-6-(1'-methylbenzimidazole-2-yl)benzimidazol;1,7'-Dimethyl-2'-propyl-2,5'-bibenzimidazole;2-n-Propyl-4-methyl-;2-n-Propyl-4-Methyl-6-(1’-Methylbenzimidazol-2’-yl)Benzimidazole;2-N-PROPYL-4-METHYL-6-(1-METHYL BENZIMIDAZOL-2-YL)-BENZIMIDAZOLE;2-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazole;4-Methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazole;2-n-propyl-4-methyl-6-(methylbenzimidazol-2-yl) benzimidazole;1H-Benzimidazole-2-n-propyl-4-methyl-6-(1'-methylbenzimidazole-2'-yl);Bis-Benzoimidazole;TelMisartan IMpurity A;Telmisartan EP Impurity A;Telmisartan Impurity 2;TelMisartan Related CoMpound A;1,7'-diMethyl-2'-propyl-1H,3'H-;TelMisartan EP IMpurity A (USP RC A*);1,7'-Dimethyl-2'-Propyl-2,5'-Bi-1h-Benzimidazole;2,5'-bi-1H-Benzimidazole,1,7'-dimethyl-2'-propyl-;2-N-Propyl-4-Methyl-6-(1'-Methylbenzimidazol-2-Yl)Benzimidazole |
| CAS号 | 152628-02-9 |
| 分子式 | C19H20N4 |
| 分子量 | 304.39 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
